Evidence map›Paper›PMID 31437325›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2019

IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.

Stephen C Dreskin, Matthew Germinaro, Dominik Reinhold, Xueni Chen, Brian P Vickery, Michael Kulis, A Wesley Burks, Surendra S Negi, Werner Braun, Jeffery M Chambliss and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02192866 (Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02192866 recruitingnot on this map

Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies

TypeobservationalSponsorUniversity of Colorado, DenverRan2014 to 2030Enrolled270ConditionsPeanut Allergies, Tree Nut Allergies, Other Food Allergies
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Human Monoclonal IgE Antibodies-a Major Milestone in Allergy.Current allergy and asthma reports · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Mechanisms of oral immunotherapy.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Review
  16. Improving Diagnostic Accuracy in Food Allergy.The journal of allergy and clinical immunology. In practice · 2021
    Review
  17. Emerging Food Allergy Biomarkers.The journal of allergy and clinical immunology. In practice · 2020
    Review
  18. Review
  19. Review
  20. Biomarkers in oral immunotherapy.Journal of Zhejiang University. Science. B
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Stephen C DreskinDivision of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, CO, USA.ORCID 0000-0003-3548-5530
Matthew GerminaroJanssen R&D US, LLC, Spring House, PA, USA.
Dominik ReinholdPPD, Wilmington, NC, USA.
Xueni ChenDivision of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, CO, USA.
Brian P VickeryDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Michael KulisDivision of Allergy and Immunology, Department of Pediatrics, University of North Carolina-Chapel Hill, NC, USA.
A Wesley BurksDivision of Allergy and Immunology, Department of Pediatrics, University of North Carolina-Chapel Hill, NC, USA.
Surendra S NegiSealy Center for Structural Biology and Molecular Biophysics, Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA.
Werner BraunSealy Center for Structural Biology and Molecular Biophysics, Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA.
Jeffery M ChamblissDivision of Allergy and Immunology, Department of Pediatrics, University of Texas, Dallas, TX, USA.
Spodra EgliteDivision of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, CO, USA.
Caitlin M G McNultySt. Paul Allergy and Asthma in St. Paul, MN, USA.
University of Colorado Denver · USThe University of Texas Medical Branch at Galveston · USUniversity of North Carolina at Chapel Hill · USEmory University · USJanssen (United States) · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Understanding the Mechanism of Mucosal ImmunotherapyR01AI068074 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BURKS, A. WESLEY · 2007 to 2016
$3.8M
Mapping the Critical Epitopes of Ara h 2 and Ara h 6R01AI099029 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DRESKIN, STEPHEN C · 2012 to 2015
$1.5M
Optimizing Tolerance Induction in Peanut Allergy: The DEVIL StudyK23AI099083 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VICKERY, BRIAN · 2012 to 2015
$494k
Prediction and Classification of Allergenicity in a Protein FamilyR21AI109090 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRAUN, WERNER A · 2014 to 2015
$440k
Designing peptides to block Ara h 2 and Ara h 6 from binding to IgER21AI135397 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DRESKIN, STEPHEN C · 2019 to 2020
$427k
NCATS NIH HHS UL1 TR002535NCATS NIH HHS UL1TR002535NIAID NIH HHS K23 AI099083NIAID NIH HHS R01 AI068074NIAID NIH HHS R01 AI099029NIAID NIH HHS R21 AI109090NIAID NIH HHS R21 AI135397
6 · The paper itself

Abstract

backgroundFor patients with peanut allergy, there are currently no methods to predict who will develop sustained unresponsiveness (SU) after oral immunotherapy (OIT).

objectiveAssess IgE binding to peanut (PN), Ara h 2, and specific linear epitopes of Ara h 2 as predictors of the important clinical parameters: eliciting dose threshold and attainment of SU following OIT.

methodsSamples and clinical data were collected from children undergoing OIT. PN- and Ara h 2-sIgE were quantified by ImmunoCAP

resultsValues of PN-sIgE correlated with eliciting dose (P = .001) and with a higher likelihood of achieving SU (P < .0001), but these relationships were lost at higher values for PN-sIgE (≥14 kIU for eliciting dose and ≥35 kIU/L for SU). In subjects with PN-sIgE ≥ 14 kIU/L, binding of IgE to epitopes 5 and 6 of Ara h 2 was associated with a lower eliciting dose at baseline challenge (P < .001; P

conclusionIn young patients with peanut allergy, measurement of PN-sIgE and IgE binding to specific linear epitopes of Ara h 2 in baseline samples may allow stratification of patients regarding sensitivity to challenge and outcome of OIT.

Indexed as

2S Albumins, PlantAdministration, OralAllergensAnimalsAntigens, PlantArachisChild, PreschoolDesensitization, ImmunologicEpitopesFemaleHumansImmunoglobulin EMalePeanut HypersensitivityPeptide MappingProtein Binding2S Albumins, PlantAllergensAntigens, PlantAra h 2 allergen, Arachis hypogaeaEpitopesImmunoglobulin Eallergensfood allergyIgEimmunotherapyoral immunotherapypeanut allergytolerance induction

Identifiers

PMID31437325
PMCPMC6906227
OpenAlexW2969631456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.